Lagis Enterprise Co., Ltd. (TPEX:6730)
Taiwan · Delayed Price · Currency is TWD 32.05
-0.25 (-0.77%)
Sep 8, 2026, 12:59 PM CST
Lagis Enterprise Market Cap
Lagis Enterprise has a market cap or net worth of 1.17 billion as of September 8, 2026. Its market cap has decreased by -19.32% in one year.
Market Cap
1.17B
Enterprise Value
1.32B
Revenue
492.35M
Ranking
n/a
PE Ratio
16.41
Stock Price
32.05
ChartMarket Cap Chart
Since November 8, 2019, Lagis Enterprise's market cap has decreased from 2.35B to 1.17B, a decrease of -50.18%. That is a compound annual growth rate of -9.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 1.17B | -8.76% |
| Dec 31, 2025 | 1.28B | 4.16% |
| Dec 31, 2024 | 1.23B | 1.45% |
| Dec 29, 2023 | 1.22B | 17.47% |
| Dec 29, 2022 | 1.04B | -2.56% |
| Dec 30, 2021 | 1.06B | -4.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ICARES Medicus | 3.67B |
| SciVision Biotech | 3.52B |
| Maxigen Biotech | 3.43B |
| Nang Kuang Pharmaceutical | 3.22B |
| Crystalvue Medical | 1.88B |
| BenQ Medical Technology | 1.79B |
| Chi Sheng Pharma & Biotech | 1.72B |
| Ttbio | 1.14B |